Teva Pharmaceutical Industries has launched the first generic version of Sandostatin LAR Depot in the U.S., offering a more affordable treatment option for patients with acromegaly and severe diarrhea associated with carcinoid syndrome. The launch comes amidst potential market impacts related to recent events in the Middle East.